Revenue
2022
2023
2024
2025
Chemomab Therapeutics Ltd. (CMMB)
Price$2.65Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | — | — | — | — | — | — |
| Research & development | $5.8M | $11.3M | $18.4M | $17.0M | $6.3M | $4.7M | $13.3M | $7.5M | $6.2M | $2.4M |
| Operating expenses | $9.6M | $14.7M | $25.5M | $28.5M | $12.4M | $6.0M | $22.9M | $13.0M | — | — |
| Operating income | −$112.0M | −$103.0M | −$25.5M | −$28.5M | — | — | — | −$13.0M | −$9.4M | −$4.6M |
| EBITDA | −$111.9M | −$102.9M | −$25.4M | −$28.5M | — | — | — | −$13.0M | — | — |
| Net income | −$9.0M | −$13.9M | −$24.2M | −$27.6M | −$12.5M | −$6.0M | −$27.1M | −$13.8M | −$9.8M | −$4.7M |
| Basic EPSper basic share | $0.02 | $0.04 | $0.10 | $0.12 | $0.06 | $0.04 | $0.79 | $1.09 | $1.09 | $0.87 |
| Diluted EPSper diluted share | $0.02 | $0.04 | $0.10 | $0.12 | $0.06 | $0.04 | $0.79 | $1.09 | $1.09 | $0.87 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
CITADEL ADVISORS LLC | 95.31K |
ADAR1 Capital Management, LLC | 80K |
KESTRA PRIVATE WEALTH SERVICES, LLC | 61.71K |
Ikarian Capital, LLC | 51.79K |
RHUMBLINE ADVISERS | 30.53K |
XTX Topco Ltd | 15.99K |
Philadelphia Investment Partners, LLC | 15K |
Lido Advisors, LLC | 14.34K |
BNP PARIBAS FINANCIAL MARKETS | 6.81K |
GAMMA Investing LLC | 4.74K |
MORGAN STANLEY | 3.58K |
SBI Securities Co., Ltd. | 34 |
Caitong International Asset Management Co., Ltd | 8 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026Form 4 | Mor George AdiChief Executive Officer | BuyAmerican Depositary Shares | 4.9K | $2.08 | $10.2K | 139.1K |
| May 29, 2026Form 4 | Mor George AdiChief Executive Officer | BuyAmerican Depositary Shares | 4.9K | $2.05 | $10.0K | 134.2K |